Free Trial

Vontier (VNT) Competitors

Vontier logo
$38.08 -0.86 (-2.21%)
(As of 11/15/2024 ET)

VNT vs. TER, AVTR, RVTY, BIO.B, NVMI, ST, MIR, TRNS, CTKB, and LAB

Should you be buying Vontier stock or one of its competitors? The main competitors of Vontier include Teradyne (TER), Avantor (AVTR), Revvity (RVTY), Bio-Rad Laboratories (BIO.B), Nova (NVMI), Sensata Technologies (ST), Mirion Technologies (MIR), Transcat (TRNS), Cytek Biosciences (CTKB), and Standard BioTools (LAB). These companies are all part of the "measuring and control equipment" industry.

Vontier vs.

Vontier (NYSE:VNT) and Teradyne (NASDAQ:TER) are both business services companies, but which is the better stock? We will compare the two companies based on the strength of their community ranking, dividends, valuation, analyst recommendations, profitability, risk, media sentiment, earnings and institutional ownership.

Vontier pays an annual dividend of $0.10 per share and has a dividend yield of 0.3%. Teradyne pays an annual dividend of $0.48 per share and has a dividend yield of 0.5%. Vontier pays out 3.8% of its earnings in the form of a dividend. Teradyne pays out 15.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Teradyne has a net margin of 18.75% compared to Vontier's net margin of 13.54%. Vontier's return on equity of 45.48% beat Teradyne's return on equity.

Company Net Margins Return on Equity Return on Assets
Vontier13.54% 45.48% 10.49%
Teradyne 18.75%18.56%13.91%

95.8% of Vontier shares are held by institutional investors. Comparatively, 99.8% of Teradyne shares are held by institutional investors. 0.8% of Vontier shares are held by company insiders. Comparatively, 0.4% of Teradyne shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Vontier has a beta of 1.25, meaning that its stock price is 25% more volatile than the S&P 500. Comparatively, Teradyne has a beta of 1.52, meaning that its stock price is 52% more volatile than the S&P 500.

Teradyne has lower revenue, but higher earnings than Vontier. Vontier is trading at a lower price-to-earnings ratio than Teradyne, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Vontier$3.10B1.85$376.90M$2.6114.59
Teradyne$2.74B6.10$448.75M$3.1532.57

In the previous week, Teradyne had 9 more articles in the media than Vontier. MarketBeat recorded 21 mentions for Teradyne and 12 mentions for Vontier. Teradyne's average media sentiment score of 1.21 beat Vontier's score of 1.16 indicating that Teradyne is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Vontier
8 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Teradyne
12 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Teradyne received 30 more outperform votes than Vontier when rated by MarketBeat users. However, 48.72% of users gave Vontier an outperform vote while only 43.87% of users gave Teradyne an outperform vote.

CompanyUnderperformOutperform
VontierOutperform Votes
38
48.72%
Underperform Votes
40
51.28%
TeradyneOutperform Votes
68
43.87%
Underperform Votes
87
56.13%

Vontier currently has a consensus price target of $44.50, suggesting a potential upside of 16.86%. Teradyne has a consensus price target of $142.62, suggesting a potential upside of 39.03%. Given Teradyne's higher possible upside, analysts plainly believe Teradyne is more favorable than Vontier.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Vontier
0 Sell rating(s)
3 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.63
Teradyne
1 Sell rating(s)
5 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.50

Summary

Teradyne beats Vontier on 14 of the 20 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VNT vs. The Competition

MetricVontierFluid meters & counting devices IndustryBusiness SectorNYSE Exchange
Market Cap$5.72B$6.03B$7.16B$19.82B
Dividend Yield0.26%0.44%2.33%3.50%
P/E Ratio14.5934.0126.4442.32
Price / Sales1.854.86169.6020.76
Price / Cash10.3532.3728.0021.65
Price / Book5.488.104.804.66
Net Income$376.90M$234.75M$120.67M$983.45M
7 Day Performance-4.92%-4.28%10.25%-2.12%
1 Month Performance10.50%4.28%12.59%-0.47%
1 Year Performance12.80%29.08%35.78%24.69%

Vontier Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VNT
Vontier
3.7837 of 5 stars
$38.08
-2.2%
$44.50
+16.9%
+12.8%$5.72B$3.10B14.598,000Positive News
TER
Teradyne
4.9966 of 5 stars
$107.18
+0.8%
N/A+13.0%$17.46B$2.68B34.036,500Dividend Announcement
Buyback Announcement
Analyst Revision
Positive News
Gap Down
AVTR
Avantor
4.9809 of 5 stars
$21.31
-1.3%
N/A+7.5%$14.50B$6.82B46.3314,500Options Volume
Analyst Revision
Positive News
RVTY
Revvity
3.9523 of 5 stars
$117.25
-2.1%
N/A+24.2%$14.27B$2.75B56.6411,500Positive News
BIO.B
Bio-Rad Laboratories
N/A$334.85
flat
N/A+11.6%$9.38B$2.67B-12.258,200
NVMI
Nova
4.3568 of 5 stars
$191.09
+0.9%
N/A+48.5%$5.55B$517.92M35.653,606Positive News
Gap Down
ST
Sensata Technologies
4.8814 of 5 stars
$33.01
+1.0%
N/A-2.6%$4.94B$4.05B-61.1319,400Short Interest ↓
Positive News
MIR
Mirion Technologies
1.3569 of 5 stars
$15.15
+0.7%
N/A+79.0%$3.52B$800.90M-44.563,000Options Volume
TRNS
Transcat
3.2647 of 5 stars
$110.37
+2.4%
N/A+14.3%$1.02B$259.48M55.741,104News Coverage
Positive News
CTKB
Cytek Biosciences
3.3399 of 5 stars
$6.43
-5.2%
N/A+1.4%$828.25M$193.01M-80.36500Short Interest ↓
Positive News
LAB
Standard BioTools
3.4395 of 5 stars
$1.77
-4.1%
N/A-28.2%$657.04M$106.34M-2.49620Positive News

Related Companies and Tools


This page (NYSE:VNT) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners